查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945139

全球病患自控鎮痛幫浦市場（按產品類型、技術、應用和最終用戶分類）預測（2026-2032年）

Patient-controlled Analgesic Pumps Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，病患自控鎮痛幫浦市場價值為5.4521億美元，預計2026年將成長至5.8633億美元，年複合成長率為7.09%，到2032年將達到8.8084億美元。

關鍵市場統計數據
基準年 2025 5.4521億美元
預計年份：2026年 5.8633億美元
預測年份 2032 8.8084億美元
複合年成長率 (%) 7.09%

針對病患自控鎮痛幫浦的綜合背景架構：重點在於臨床需求、不斷變化的醫療環境以及推動設備普及的相關人員期望

患者自控式鎮痛幫浦已成為現代疼痛管理的重要工具，它將患者自主權與臨床醫生的監督相結合，在急性和慢性疼痛治療​​中提供精準的鎮痛方案。這些系統的發展源於臨床需求，旨在提高鎮痛的精準度，減少鴉片類藥物相關的不利事件，並支持早期活動和出院。過去十年，臨床團隊越來越重視那些能夠實現個人化給藥，並透過可程式設計鎖定功能、劑量限制和整合監測來確保安全性的設備。

綜合審視技術、監管和醫療服務模式的變革，這些變革正在重新定義疼痛管理領域醫療設備的預期和採購標準。

隨著技術、政策和醫療服務模式的融合，患者自控鎮痛泵（PCAPP）的格局正在經歷快速變革，臨床醫生和患者對鎮痛系統的期望也隨之改變。連接性和嵌入式智慧技術的進步，使PCAPP從孤立的儀器發展成為更廣泛的數位醫療生態系統的組成部分，從而實現即時遙測、劑量審核和遠端警報，以支援更嚴格的臨床監管。同時，鴉片類藥物舉措的興起和安全性審查的加強，正在加速諸如大劑量投藥頻率限制、強制警報和支持機構遵守通訊協定等功能的應用。

2025年關稅對美國疼痛幫浦供應鏈的採購、採購策略和製造選擇的影響

2025年美國關稅的累積影響，為醫療設備製造商和醫療系統的採購、製造和供應鏈管理等各個環節帶來了新的動態。進口零件和成品關稅的徵收，使得泵浦和耗材的總到岸成本更加受到關注，促使許多製造商和經銷商重新評估籌資策略。為此，各機構正在加快供應商多元化、將關鍵製造環節外包以及重新談判長期供應商合約的步伐，以降低對單一供應來源的依賴風險。

透過詳細的細分分析，將產品設計、臨床適應症、使用環境、給藥途徑以及不斷發展的技術需求連結起來，制定針對性策略。

細分市場層面的趨勢分析突顯了產品、應用、最終用戶、給藥途徑和技術等各個維度上的明確業務促進因素和客戶期望。產品類型分為一次性彈性體裝置和定量輸注裝置，分別滿足不同的臨床和操作需求。一次性彈性體裝置在特定的門診和居家照護流程中具有一次性使用的簡便性和一次性使用便捷性，而定量輸注裝置則提供可程式設計的精確度，更適用於複雜的住院環境。臨床應用包括癌症相關疼痛、分娩和術後鎮痛，每種應用都需要個人化的給藥方案、監測技術和病患教育方法，這些都會影響裝置的選擇和照護通訊協定。

區域比較分析重點在於影響全球醫療器材普及的法規結構、醫療服務模式和製造趨勢。

區域趨勢受法規環境、報銷結構、醫療服務模式和產業能力的影響，這些因素共同作用，影響醫療器材的採用和支持方式。在美洲，重點在於監管合規性、與電子病歷的互通性以及家庭輸液模式的日益普及。報銷政策和一體化醫療體係是採購優先事項的關鍵促進因素，而該地區的製造地和分銷網路則為零部件生產的近岸外包提供了途徑。

策略競爭概覽：揭示產品線廣度、服務和軟體主導的差異化如何決定疼痛泵領域的商業領先地位

病患自控式鎮痛幫浦市場的競爭格局由技術差異化、服務產品、與臨床生態系的夥伴關係所決定。專注於與臨床工作流程整合、提供強大的售後支援以及實現數據互通性的市場參與企業，往往更受大型醫療機構的青睞，因為這些機構希望減輕臨床醫生的負擔並提高用藥安全指標。同時，提供從簡單易用的一次性泵浦到多功能可程式設計泵浦等多種產品形式的製造商，能夠更好地服務於包括醫院、門診中心和居家照護機構在內的各種採購管道。

為製造商、醫療系統和支付者提供具體、實用的建議，以提高醫療設備的採用率、降低風險並創造臨床價值。

產業領導者應採取一系列協作行動，使產品開發、商業策略和營運韌性與不斷變化的臨床需求保持一致。製造商應將互通性作為核心設計原則，並確保設備支援電子病歷 (EMR) 整合和無線連接，以促進封閉回路型文件記錄和遠端監測。加強服務模式同樣重要：投資於全面的培訓、快速響應的技術支援以及完善的保固和耗材供應計劃，將降低醫院和居家照護機構採用這些設備的門檻。

本分析所依據的研究透過嚴謹的多方法研究方案檢驗了研究結果，該方案結合了臨床訪談、監管審查、產品評估和供應鏈分析。

本分析所依據的研究整合了多方面的證據，以確保其嚴謹性和實用性。主要數據包括對急診和門診臨床醫生、生物醫學工程專家、供應鏈負責人以及有家庭輸液經驗的看護者進行的結構化訪談，旨在了解他們對設備可用性、安全問題和採購因素的現場觀點。次要研究則納入了對監管申報文件、臨床指南、鎮痛藥物給藥方面的同行評審文獻以及公共文件的分析，以闡明影響設備設計的法規環境和標準。

綜合結論強調了客製化解決方案、互通性和相關人員之間的協作對於實現設備價值的重要性。

病患自控式鎮痛幫浦在臨床療效、病患自主管理和營運效率三者之間發揮著至關重要的作用。技術進步、監管重點以及不斷變化的醫療環境，都在拓展人們對這類設備功能的期望，同時也提升了互通性、服務模式和供應鏈韌性的重要性。從產品形態、臨床應用到給藥途徑和最終用戶環境等各個方面的詳細細分，凸顯了「一刀切」解決方案的局限性。針對不同環境（無論是門診手術中心、居家照護計畫或醫院系統）的獨特需求制定專門策略，對於持續推廣應用至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的患者自控式鎮痛幫浦市場

  • 一次性彈性體裝置
  • 定量輸液設備

9. 按技術分類的病人自控式鎮痛幫浦市場

  • 彈性體裝置
  • 智慧泵浦
    • 電子病歷整合
    • 無線連線
  • 傳統泵浦

10. 按應用分類的病患自控式鎮痛幫浦市場

  • 癌症相關疼痛
  • 分娩期間
  • 術後止痛

第11章 依最終用戶分類的病患自控式止痛幫浦市場

  • 門診手術中心
  • 居家醫療環境
  • 醫院

12. 按地區分類的病患自控式鎮痛幫浦市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 按組別分類的病人自控式止痛幫浦市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國患者自控鎮痛幫浦市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國病患自控鎮痛幫浦市場

第16章 中國病人自控鎮痛幫浦市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Ace Medical
  • Avanos Medical, Inc.
  • Becton, Dickinson and Company
  • Braun Melsungen AG
  • Eitan Medical
  • Flowonix Medical
  • Fresenius Kabi
  • Halyard Health
  • ICU Medical, Inc.
  • IntraPump Infusion Systems
  • Koninklijke Philips NV
  • Medtronic plc
  • Mindray Medical International Limited
  • Moog Inc.
  • Nipro Corporation
  • Promecon Medizintechnik GmbH
  • Smiths Medical
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-C67B9E988F42

The Patient-controlled Analgesic Pumps Market was valued at USD 545.21 million in 2025 and is projected to grow to USD 586.33 million in 2026, with a CAGR of 7.09%, reaching USD 880.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 545.21 million
Estimated Year [2026] USD 586.33 million
Forecast Year [2032] USD 880.84 million
CAGR (%) 7.09%

Comprehensive contextual framing of patient-controlled analgesic pumps highlighting clinical imperatives, care setting shifts, and stakeholder expectations driving device adoption

Patient-controlled analgesic pumps have become an essential tool in contemporary pain management, bridging patient autonomy and clinician oversight to deliver targeted analgesia across acute and chronic care settings. The evolution of these systems has been driven by clinical imperatives to improve analgesic precision, reduce opioid-related adverse events, and support early mobilization and discharge pathways. Over the past decade, clinical teams have increasingly prioritized devices that enable individualized dosing while preserving safety through programmable lockouts, dose limits, and integrated monitoring.

As care shifts beyond the inpatient ward, pumps are now fundamental to ambulatory surgical centers, home infusion programs, and labor and delivery suites, creating new demands for portability, ease of use, and interoperability. Stakeholders from procurement leaders to bedside nurses and biomedical engineers seek solutions that balance operational reliability with streamlined training and clear documentation. Consequently, device manufacturers and health systems are collaborating more closely to align product design with workflow realities, electronic health record integration, and post-discharge support. This introduction establishes the clinical and operational context for deeper analysis of technological advances, regulatory drivers, and buyer behavior that collectively shape the patient-controlled analgesic pump landscape.

An integrated view of technological, regulatory, and care delivery shifts that are redefining device expectations and procurement criteria in analgesia management

The landscape for patient-controlled analgesic pumps is undergoing rapid transformation as converging forces in technology, policy, and care delivery redefine what clinicians and patients expect from analgesia systems. Advances in connectivity and embedded intelligence have moved devices beyond isolated instruments into components of broader digital care ecosystems, enabling real-time telemetry, dose auditing, and remote alerts that support tighter clinical oversight. At the same time, the rise of opioid stewardship initiatives and heightened scrutiny on safety have accelerated adoption of features that limit bolus frequency, implement mandatory alarms, and support compliance with institutional protocols.

Concurrent shifts in care delivery patterns, particularly the expansion of home-based infusion and shorter inpatient stays, have elevated demand for compact, user-friendly pumps that require minimal technical oversight. Manufacturers are responding by simplifying interfaces, improving battery life, and designing disposables that reduce reprocessing burdens. Interoperability expectations are also reshaping procurement criteria; buyers increasingly demand devices that integrate seamlessly with electronic medical records and supply chain systems. Finally, regulatory emphasis on cybersecurity, data integrity, and post-market surveillance is compelling manufacturers to invest in secure architectures and enhanced post-sale support, which in turn affects product roadmaps and sales strategies.

How the 2025 tariff regime reshaped sourcing, procurement strategies, and manufacturing choices for analgesic pump supply chains across the United States

The cumulative effects of the United States tariffs implemented in 2025 have introduced new dynamics across procurement, manufacturing, and supply chain management for device producers and health systems. Tariffs on imported components and finished devices have sharpened attention on the total landed cost of pumps and consumables, prompting many manufacturers and distributors to re-evaluate sourcing strategies. In response, organizations have accelerated efforts to diversify suppliers, nearshore critical manufacturing elements, and renegotiate long-term supplier contracts to mitigate single-source exposure.

Hospitals and other purchasers have reacted by revisiting contract terms and increasing scrutiny of supplier value propositions to offset elevated acquisition costs. Some providers have intensified focus on standardization across device fleets to reduce inventory complexity and to consolidate purchasing power during renegotiation cycles. Moreover, the tariffs have spurred a renewed interest in domestic manufacturing incentives and public-private partnerships that can insulate essential medical device supply lines from geopolitical and trade disruptions. These developments have also influenced product design priorities: manufacturers are evaluating component substitution, modular architectures, and simplified bill-of-materials to reduce tariff sensitivity while maintaining safety and usability standards.

In-depth segmentation analysis connecting product design, clinical indication, user setting, administration route, and evolving technology requirements for targeted strategies

Segment-level dynamics reveal distinct performance drivers and customer expectations across product, application, end user, route of administration, and technology dimensions. Based on product type, the market is organized into disposable elastomeric devices and volumetric infusion devices, with each pathway addressing different clinical and operational needs; disposable elastomeric options offer simplicity and single-use convenience for certain ambulatory and home care workflows, while volumetric infusion devices offer programmable precision favored in complex inpatient settings. In clinical applications, devices are deployed across cancer-related pain, labor and delivery, and postoperative analgesia, each area demanding tailored dosing profiles, monitoring practices, and patient education approaches that influence device selection and care protocols.

The end-user perspective further differentiates requirements: ambulatory surgical centers prioritize rapid turnover and compact solutions, home care settings require portability, clear instructions, and reliable disposables, and hospitals demand full-featured devices with advanced alarm and monitoring capabilities. Routes of administration-epidural, intravenous, regional block, and subcutaneous-introduce clinical constraints and safety considerations that inform dosing algorithms and accessory needs. From a technology standpoint, the landscape spans elastomeric devices, smart pumps, and traditional pumps; smart pumps, which are increasingly in demand, are further analyzed across EMR-integrated configurations and units offering wireless connectivity, enabling closed-loop documentation, remote updates, and analytics-driven medication safety programs. Together these segmentation layers shape product roadmaps, clinical training investments, and aftermarket service models.

Comparative regional analysis highlighting regulatory frameworks, care delivery models, and manufacturing dynamics shaping device adoption worldwide

Regional dynamics are shaped by regulatory environments, reimbursement structures, care delivery models, and industrial capabilities that collectively influence how devices are adopted and supported. The Americas display a high emphasis on regulatory compliance, interoperability with electronic records, and increasing penetration of home infusion models; reimbursement policies and consolidated health systems are important determinants of procurement priorities, while manufacturing hubs and distribution networks in the region provide avenues for nearshoring component production.

Europe, Middle East & Africa present a varied mosaic in which stringent regional regulatory frameworks, diverse payer mechanisms, and heterogeneous clinical pathways create both opportunities and complexities for market entry and device scaling. In parts of the region, centralized procurement and national health programs favor standardization, while other markets are driven by private hospital systems seeking advanced connectivity and analytics capabilities. Asia-Pacific demonstrates a broad spectrum from advanced tertiary centers in urban markets adopting smart pump solutions with EMR integration to rapidly expanding homecare infrastructures in emerging markets; local manufacturing capability, differing regulatory timelines, and the availability of trained clinical personnel influence adoption patterns and service models across the region.

Strategic competitive overview revealing how product breadth, services, and software-led differentiation determine leadership in analgesic pump commercialization

Competitive dynamics across the patient-controlled analgesic pump landscape are defined by technological differentiation, service offerings, and partnerships across the clinical ecosystem. Market participants that emphasize integration with clinical workflows, robust post-sale support, and data interoperability are often viewed favorably by large health systems seeking to reduce clinician burden and improve medication safety metrics. Meanwhile, manufacturers that offer a range of product formats-from low-complexity disposables to feature-rich programmable pumps-are positioned to serve diverse purchasing channels including hospitals, ambulatory centers, and home care providers.

Strategic activity increasingly focuses on software and analytics layers as a source of differentiation, with companies investing in dose decision support, remote monitoring dashboards, and data services that translate device telemetry into actionable clinical insights. Service and training capabilities remain critical, particularly for home infusion deployments where device simplicity and caregiver education determine outcomes. Competitive pressure also encourages partnerships with electronic health record vendors, contract manufacturers, and logistics providers to secure integrated solutions that reduce implementation friction and lifecycle costs. These shifts underscore the importance of a holistic approach-product performance alone is no longer sufficient; broad-based support models and data-enabled value propositions are pivotal to commercial success.

Concrete, practicable recommendations for manufacturers, health systems, and payers to accelerate adoption, reduce risk, and extract clinical value from devices

Industry leaders should pursue a set of coordinated actions that align product development, commercial strategy, and operational resilience with evolving clinical needs. Manufacturers ought to prioritize interoperability as a core design principle, ensuring that devices support EMR integration and wireless connectivity to facilitate closed-loop documentation and remote monitoring. Strengthening service models is equally important: investing in comprehensive training, rapid-response technical support, and robust warranty and consumable supply programs will lower adoption barriers for hospitals and homecare providers.

Supply chain resilience must be addressed through supplier diversification, strategic nearshoring of critical components, and modular product architectures that allow component substitution without compromising safety. From a commercial perspective, companies should explore outcome-based contracting and evidence-generation partnerships with clinical centers to validate real-world benefits and support procurement discussions. Providers and payers, for their part, can standardize device fleets where clinically appropriate to simplify training and inventory management while piloting smart pump programs linked to analytics to measure safety and cost outcomes. Across stakeholders, a clear focus on cybersecurity, regulatory alignment, and user-centered design will accelerate adoption and protect both patients and institutional investments.

Robust multi-method research approach combining primary clinical interviews, regulatory review, product assessments, and supply chain mapping to validate insights

The research underpinning this analysis combined multiple evidence streams to ensure rigor and practical relevance. Primary inputs included structured interviews with clinicians across acute and ambulatory care settings, biomedical engineering professionals, supply chain leaders, and caregivers experienced in home infusion to capture frontline perspectives on device usability, safety concerns, and procurement drivers. Secondary research incorporated regulatory filings, clinical guidelines, peer-reviewed literature on analgesia delivery, and analysis of public policy documents to contextualize the regulatory environment and standards affecting device design.

Supplementary methods involved mapping supplier networks and manufacturing footprints, reviewing product feature sets through technical specifications and marketing materials, and assessing interoperability capabilities via integration statements and standards adherence. Findings were triangulated across data sources to validate thematic conclusions and identify gaps for further inquiry. Limitations of the approach chiefly relate to the evolving nature of device firmware updates, regional reimbursement variability, and the pace of post-market evidence generation, which require periodic refreshes to maintain the currency of recommendations.

Synthesized conclusions emphasizing the necessity of tailored solutions, interoperability, and cross-stakeholder collaboration to realize device value

Patient-controlled analgesic pumps occupy a pivotal role at the intersection of clinical efficacy, patient empowerment, and operational efficiency. The confluence of technology advances, regulatory focus, and shifting care settings has expanded the capabilities expected from these devices while elevating the importance of interoperability, service models, and supply chain resilience. Segmentation nuances-from product formats and clinical applications to administration routes and end-user environments-underscore that one-size-fits-all solutions are increasingly insufficient; tailored strategies that address the distinct needs of ambulatory surgical centers, home care programs, and hospital systems will be essential for sustained adoption.

Looking ahead, stakeholders that align product design with real-world workflows, invest in data-driven safety and performance features, and strengthen their supply and service ecosystems will be best placed to capture clinical and commercial value. Ongoing collaboration between manufacturers, clinicians, and health systems will remain critical to translate device capabilities into measurable improvements in patient outcomes and operational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patient-controlled Analgesic Pumps Market, by Product Type

  • 8.1. Disposable Elastomeric Devices
  • 8.2. Volumetric Infusion Devices

9. Patient-controlled Analgesic Pumps Market, by Technology

  • 9.1. Elastomeric Devices
  • 9.2. Smart Pumps
    • 9.2.1. Emr Integrated
    • 9.2.2. Wireless Connectivity
  • 9.3. Traditional Pumps

10. Patient-controlled Analgesic Pumps Market, by Application

  • 10.1. Cancer Related Pain
  • 10.2. Labor And Delivery
  • 10.3. Postoperative Analgesia

11. Patient-controlled Analgesic Pumps Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals

12. Patient-controlled Analgesic Pumps Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Patient-controlled Analgesic Pumps Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Patient-controlled Analgesic Pumps Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Patient-controlled Analgesic Pumps Market

16. China Patient-controlled Analgesic Pumps Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Ace Medical
  • 17.7. Avanos Medical, Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Braun Melsungen AG
  • 17.10. Eitan Medical
  • 17.11. Flowonix Medical
  • 17.12. Fresenius Kabi
  • 17.13. Halyard Health
  • 17.14. ICU Medical, Inc.
  • 17.15. IntraPump Infusion Systems
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Medtronic plc
  • 17.18. Mindray Medical International Limited
  • 17.19. Moog Inc.
  • 17.20. Nipro Corporation
  • 17.21. Promecon Medizintechnik GmbH
  • 17.22. Smiths Medical
  • 17.23. Stryker Corporation
  • 17.24. Teleflex Incorporated
  • 17.25. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY DISPOSABLE ELASTOMERIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY DISPOSABLE ELASTOMERIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY DISPOSABLE ELASTOMERIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY VOLUMETRIC INFUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY VOLUMETRIC INFUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY VOLUMETRIC INFUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY ELASTOMERIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY ELASTOMERIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY ELASTOMERIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY EMR INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY EMR INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY EMR INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TRADITIONAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TRADITIONAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TRADITIONAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY CANCER RELATED PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY CANCER RELATED PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY CANCER RELATED PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY LABOR AND DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY LABOR AND DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY LABOR AND DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY POSTOPERATIVE ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY POSTOPERATIVE ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY POSTOPERATIVE ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 106. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 124. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 130. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)